Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by (18)F-FDG PET/CT Radiomics and Clinicopathological Characteristics

PURPOSE: In the present study, we aimed to evaluate the expression of programmed death-ligand 1 (PD-L1) in patients with non-small cell lung cancer (NSCLC) by radiomic features of (18)F-FDG PET/CT and clinicopathological characteristics. METHODS: A total 255 NSCLC patients (training cohort: n = 170;...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jihui, Ge, Shushan, Sang, Shibiao, Hu, Chunhong, Deng, Shengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716940/
https://www.ncbi.nlm.nih.gov/pubmed/34976829
http://dx.doi.org/10.3389/fonc.2021.789014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716940/
https://www.ncbi.nlm.nih.gov/pubmed/34976829
http://dx.doi.org/10.3389/fonc.2021.789014

Ejemplares similares